Negotiating valuation without losing the investor or the company
How to arrive at a number you can defend, the four arguments that work, the three that don't, when to hold and when to move, and the trade-offs that are worth more than a higher price.
Valuation is where founders feel the most pressure and have the least information. Investors have seen fifty rounds; you have seen one. The way through is not to out-negotiate them — you will not — but to arrive with a number you can explain from evidence, know which terms matter more than the number, and be willing to lose an investor who will only pay a price that leaves you unable to raise again.
Arriving at the number
Start from what the traction supports: a multiple of revenue or profit that comparable businesses at your stage raised at in the last year. Check it against dilution: does the raise you need, at this valuation, leave founders with a comfortable majority after this round and a plausible next one? Check it against the investor's needs: does their ticket get them a meaningful stake? Where those three overlap is your number. Write down the reasoning in five lines; you will need to say it out loud.
Four arguments that work
- Comparables. "Three UK businesses at our stage in our sector raised at £2–3m pre in the last twelve months; here they are." Investors respect evidence about the market.
- Trajectory. "We were at £12k MRR in January and £38k now. At this rate we are £60k by the close and the valuation is a discount to where we will be." Growth that is continuing during the raise is the strongest argument there is.
- The next round. "At £1.6m pre we give away 20%; the next round at £6m gives another 20% and founders still hold 64%. At £1m pre that falls below 50% and nobody funds a company where the founders have lost control." Investors understand cap-table arithmetic and do not want a dead company either.
- SEIS/EIS. "Your effective cost per share after relief is half the headline." It does not change the valuation, but it changes how the investor feels about it.
Three that don't
- "We need this valuation to make the dilution work." That is your problem, not the market's.
- "A competitor raised at £10m." Unless they were at your stage with your numbers, it proves nothing.
- "We've put three years into this." Sweat is not value; investors fund the future, not the past.
When to hold and when to move
Hold when one investor objects and others have not. Hold when your reasoning is sound and the objection is "it feels high". Move when three serious investors independently land on the same lower number — that is the market, not a negotiation. Move when the investor is the right lead and the gap is under 20%. Never move in response to silence; ask first.
Trade-offs worth more than the price
A 15% lower valuation with one class of ordinary shares, founder-friendly leaver terms and a short consent list is a better deal than a 15% higher one with preference shares, a pre-money option pool and a board majority. The number is the thing founders fight over and the terms are where investors win. Decide before the negotiation what you will trade: usually, some valuation for clean terms and a good lead.
Questions founders ask
"The investor wants to set the valuation. Should I let them?"
Let them make the first offer if you like — it tells you where they are — but have your number and your reasoning ready. An investor who sees you have done the work prices more fairly than one who sees you have not.
"Is it better to raise at a lower valuation now and a higher one later?"
Usually yes, if "lower" still leaves founders in control. A round that closes at a fair price beats one that stalls at a high one, and every round that closes makes the next easier.
"What if my co-founder and I disagree on the number?"
Agree before you list. Investors will find the gap in the first call and use it.